Literature DB >> 30942896

Real-World Evidence of Treatment Effects: The Useful and the Misleading.

Sebastian Schneeweiss1.   

Abstract

Year:  2019        PMID： 30942896     DOI： 10.1002/cpt.1405

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  9 in total

1.  The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers.

Authors:  Nicole Pratt; Ximena Camacho; Claire Vajdic; Louisa Degenhardt; Tracey-Lea Laba; Jodie Hillen; Christopher Etherton-Beer; David Preen; Louisa Jorm; Natasha Donnolley; Alys Havard; Sallie-Anne Pearson
Journal:  Int J Popul Data Sci       Date:  2022-06-13

2.  Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.

Authors:  Jessica M Franklin; Elisabetta Patorno; Rishi J Desai; Robert J Glynn; David Martin; Kenneth Quinto; Ajinkya Pawar; Lily G Bessette; Hemin Lee; Elizabeth M Garry; Nileesa Gautam; Sebastian Schneeweiss
Journal:  Circulation       Date:  2020-12-17       Impact factor: 29.690

3.  When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?

Authors:  Gregory E Simon; Richard Platt; Jonathan H Watanabe; Andrew B Bindman; Alex John London; Michael Horberg; Adrian Hernandez; Robert M Califf
Journal:  Clin Pharmacol Ther       Date:  2021-05-19       Impact factor: 6.903

Review 4.  Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.

Authors:  Hans-Georg Eichler; Franz Koenig; Peter Arlett; Harald Enzmann; Anthony Humphreys; Frank Pétavy; Brigitte Schwarzer-Daum; Bruno Sepodes; Spiros Vamvakas; Guido Rasi
Journal:  Clin Pharmacol Ther       Date:  2019-10-01       Impact factor: 6.875

5.  Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment.

Authors:  Seamus Kent; Edward Burn; Dalia Dawoud; Pall Jonsson; Jens Torup Østby; Nigel Hughes; Peter Rijnbeek; Jacoline C Bouvy
Journal:  Pharmacoeconomics       Date:  2020-12-18       Impact factor: 4.981

6.  The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation.

Authors:  Torbjörn Callréus
Journal:  Pharmaceut Med       Date:  2022-07-25

7.  Comparing direct acting antivirals for hepatitis C using observational data - Why and how?

Authors:  Jim Young; Stanley Wong; Naveed Z Janjua; Marina B Klein
Journal:  Pharmacol Res Perspect       Date:  2020-10

8.  Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.

Authors:  Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 19.871

9.  Data Sources for Drug Utilization Research in Brazil-DUR-BRA Study.

Authors:  Lisiane Freitas Leal; Claudia Garcia Serpa Osorio-de-Castro; Luiz Júpiter Carneiro de Souza; Felipe Ferre; Daniel Marques Mota; Marcia Ito; Monique Elseviers; Elisangela da Costa Lima; Ivan Ricardo Zimmernan; Izabela Fulone; Monica Da Luz Carvalho-Soares; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.